Rapid Review Quiz: COVID-19 Updates

Michael Stuart Bronze, MD


September 28, 2022

Using data cited in a recent Morbidity and Mortality Weekly Report, the CDC compared post-COVID symptoms and conditions between 781,419 patients aged 0-17 years with confirmed COVID-19 to another 2,344,257 without COVID-19. Specifically, they reviewed laboratory data and medical claims for these patients from March 1, 2020, through January 31, 2022, to see who had any of 15 specific long COVID–linked outcomes.

The researchers defined long COVID-19 as a condition in which symptoms begin or last for at least 4 weeks after a COVID-19 diagnosis. Compared with children who had no prior COVID-19 diagnosis, children in the long-COVID group were 101% more likely to have an acute pulmonary embolism, 99% more likely to have myocarditis or cardiomyopathy, and 87% more likely to have a venous thromboembolic event. They were also 32% more likely to have acute and unspecified renal failure and 23% more likely to have type 1 diabetes.

Patients with COVID-19 were less likely to experience respiratory symptoms, symptoms of mental conditions, anxiety and fear-related disorders, and gastrointestinal issues. The CDC researchers pointed to the importance of COVID-19 prevention in children, including vaccination.

Learn more about COVID-19 in children.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.